Entry inhibitors: a race to the finish line.
D065100:CCR5 Receptor Antagonists; D006678:HIV / Q000502:physiology*; D023581:HIV Fusion Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D008561:Membrane Fusion / Q000187:drug effects*; D019718:Receptors, CXCR4 / Q000037:antagonists & inhibitors; D019562:Viral Load
D065100:CCR5 Receptor Antagonists; D023581:HIV Fusion Inhibitors; D019718:Receptors, CXCR4